These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis. Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487 [TBL] [Abstract][Full Text] [Related]
5. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain. Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793 [TBL] [Abstract][Full Text] [Related]
6. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. Galici R; Echemendia NG; Rodriguez AL; Conn PJ J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306 [TBL] [Abstract][Full Text] [Related]
7. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Kang J; Chen J; Shi Y; Jia J; Zhang Y Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Chiechio S; Copani A; De Petris L; Morales ME; Nicoletti F; Gereau RW Mol Pain; 2006 Jun; 2():20. PubMed ID: 16764720 [TBL] [Abstract][Full Text] [Related]
10. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499 [TBL] [Abstract][Full Text] [Related]
11. Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons. Lin S; Nazif K; Smith A; Baas PW; Smith GM J Neurosci Res; 2015 Aug; 93(8):1215-28. PubMed ID: 25702820 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity. Cao DY; Bai G; Ji Y; Traub RJ Gut; 2015 Dec; 64(12):1913-20. PubMed ID: 25378524 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786 [TBL] [Abstract][Full Text] [Related]
14. Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain. Osikowicz M; Skup M; Mika J; Makuch W; Czarkowska-Bauch J; Przewlocka B Pain; 2009 Dec; 147(1-3):175-86. PubMed ID: 19782473 [TBL] [Abstract][Full Text] [Related]
15. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain. Mazzitelli M; Neugebauer V Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647 [TBL] [Abstract][Full Text] [Related]
16. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. Cartmell J; Monn JA; Schoepp DD J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice. Liang DY; Li X; Clark JD J Pain; 2013 Jan; 14(1):36-47. PubMed ID: 23273833 [TBL] [Abstract][Full Text] [Related]
18. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats. Pitsikas N; Markou A Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090 [TBL] [Abstract][Full Text] [Related]
20. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]